BOSTON — The following statement was issued by Lucy Westerfield, deputy executive director of Patients For Affordable Drugs Now, following the Massachusetts state Senate passage of S 2651, An Act relative to pharmaceutical access, costs, and transparency, to lower drug prices:

“We applaud the Massachusetts state Senate for passing S 2651 to rein in rising prescription drug costs for Massachusetts patients. Every day, patients are forced to choose between medications they need and paying for groceries. They need relief. This bill will empower the state to review unreasonable drug prices and develop programs to make expensive drugs more affordable for Bay Staters, especially those disproportionately impacted by high drug prices. It’s time for the full legislature to stand up for patients and send S 2651 to Governor Baker’s desk — patients cannot wait any longer.”